Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shuji Masatani"'
Autor:
Yutaka Ariyoshi, Koji Kakihata, Jun-ichi Tadokoro, Shuji Masatani, Masahiro Fukuoka, Yuh Sakata, Tomoo Shiozawa, Minoru Shimazaki, Fumie Yamaguchi
Publikováno v:
Japanese Journal of Clinical Oncology. 41:1101-1111
Objective: The actual condition of drug utilization and the adverse drug reactions profile of irinotecan hydrochloride hydrate (irinotecan), an antitumor drug, were examined on the basis of all the case survey results from April 1995 to January 2000.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38cdf857410e41369936df02dd07d704
https://doi.org/10.1093/jjco/hyr105
https://doi.org/10.1093/jjco/hyr105
Autor:
Koji Fujino, Satoshi Morita, Akihiko Gemma, Jun-ichi Tadokoro, Narikazu Boku, Toshitaka Fujiki, Tomoo Shiozawa, Shuji Masatani, Koji Kakihata
Publikováno v:
Japanese Journal of Clinical Oncology
Objectives This analysis was conducted to clarify risk factors for severe adverse effects and treatment-related deaths reported during a postmarketing survey of irinotecan. Methods The survey covered all patients treated with irinotecan in Japan betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::903e5d233910054fe52064b66316a09f
https://pubmed.ncbi.nlm.nih.gov/23536639
https://pubmed.ncbi.nlm.nih.gov/23536639